Target intelligence / Profile preview

Carbonyl group

Molecular classification
Chemical functional group, Reactive species, Other
01

Overview

Carbonyl groups (C=O) are chemical functional groups consisting of a carbon atom double-bonded to an oxygen atom, found in aldehydes, ketones, and carboxylic acids. In a therapeutic context, the term refers to 'Reactive Carbonyl Species' (RCS) or 'protein carbonyls,' which are products of oxidative stress and non-enzymatic glycation (Dalle-Donne et al., 2003, PubMed: 12765468). RCS such as methylglyoxal and malondialdehyde are highly reactive and can modify proteins, lipids, and DNA, leading to the formation of advanced glycation end-products (AGEs) and advanced lipoxidation end-products (ALEs). These modifications are central to the pathogenesis of chronic conditions, including diabetic complications, atherosclerosis, and neurodegenerative disorders like Alzheimer's disease (Negre-Salvayre et al., 2008, British Journal of Pharmacology). Although not a specific protein target like a receptor or enzyme, carbonyl groups are targeted by 'carbonyl scavengers'—small molecules designed to chemically sequester these reactive species before they cause irreversible damage (Mecocci et al., 1999, Free Radical Biology and Medicine). Clinical interest in these groups primarily focuses on their role as biomarkers for oxidative damage and as a strategy for mitigating the 'carbonyl stress' associated with aging and metabolic disease.

Other names
C=O groupCarbonyl moietyReactive Carbonyl SpeciesProtein carbonylsRCS
02

Mechanism of action

Nucleophilic scavenging and sequestration of reactive carbonyl species (RCS) to prevent the formation of advanced glycation end-products (AGEs) and protein cross-linking (Negre-Salvayre et al., 2008).

03

Biological functions

Oxidative stress signalingProtein modificationMetabolic byproduct formationOther
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseInflammationOther
05

Safety considerations

Off-target reactivity with essential physiological carbonyls (e.g., pyridoxal phosphate)Systemic toxicity of scavengersLack of specificity for pathological vs. physiological carbonyls
06

Interacting drugs

Hydralazine

4 more in the full profile.

07

Biomarkers

Protein carbonyl content (PCC)2,4-Dinitrophenylhydrazine (DNPH) reactivityAdvanced glycation end-products (AGEs)

Beyond the preview

Go deeper on Carbonyl group.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbonyl group.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call